<DOC>
	<DOCNO>NCT00411957</DOCNO>
	<brief_summary>Several study HIV-NAT demonstrate high nevirapine , indinavir , saquinavir lopinavir/r level compare Caucasian patient . Until , pharmacokinetics atazanavir explore Thai population . We postulate ATV level , PIs , high Thai people . Therefore , level ATV ATV/RTV 300/100 OD may higher acceptable range could associate ATV related toxicity .</brief_summary>
	<brief_title>Pharmacokinetic Study 2 Doses ATV/r OD + 2 NRTIs Thai HIV-1 Infected Patients</brief_title>
	<detailed_description>We interested daily ATV/RTV 200/100 mg OD convenience , reduction ATV dose may improve adherence reduce toxicity cost . There limited prospective study evaluate pharmacokinetic long term efficacy safety atazanavir/ritonavir daily dose combination NRTIs HIV-1 pretreated patient . We believe PK parameter ATV/RTV give 200/100mg daily Thai patient equivalent ATV/RTV 300/100mg daily dose Caucasian patient combine 2NRTIs , daily regimen well safety , tolerability profile , cost save maintain good CD4 VL outcome . If , pharmacokinetic profile ATV/RTV 200/100 mg OD + 2NRTIs acceptable range comparable standard dose ATV/RTV 300/100 mg OD , long term efficacy explore later .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Atazanavir Sulfate</mesh_term>
	<criteria>Written inform consent Adults HIV patient currently use ATV/RTV 300/100 mg OD plus 2 NRTIs HIV RNA &lt; 50 copies/ml Inability understand nature extent study procedure require . ALT/ AST 5x upper limit Relevant history current condition , illness might interfere drug absorption , distribution , metabolism excretion . Use concomitant medication may interfere pharmacokinetics atazanavir , ritonavir History sensitivity/idiosyncrasy drug chemically related compound may employ study . Active drug abuse heavy alcoholic drink History sensitivity/idiosyncrasy drug chemically related compound may employ study . Active drug abuse heavy alcoholic drinking</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>atazanavir/ritonavir</keyword>
	<keyword>pharmacokinetic ATV/r200/100 OD+2NRTIs</keyword>
</DOC>